EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Targeted tissue delivery of RNA therapeutics using antibody–oligonucleotide conjugates (AOCs)

Barbora Malecova, Rob S Burke, Michael Cochran, Michael D Hood, Rachel Johns, Philip R Kovach, Venkata R Doppalapudi, Gulin Erdogan, J Danny Arias, Beatrice Darimont, Christopher D Miller, Hanhua Huang und 3 weitere

Nucleic Acids Research · 07.07.2023 · 51 (12) · 5901-5910

DOI: 10.1093/nar/gkad415 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nucleic Acids Research, online erschienen am 24.05.2023. Verfasst von Barbora Malecova und 14 weiteren Autor:innen. Beteiligte Einrichtung: Avidity Biosciences, Inc., 10578 Science Center Drive Suite 125, San Diego, CA 92121, USA. Hauptthemen laut MEDLINE: Oligonucleotides, Oligonucleotides, Antisense. Die Arbeit wurde bisher 176-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Avidity Biosciences, Inc.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Although targeting TfR1 to deliver oligonucleotides to skeletal muscle has been demonstrated in rodents, effectiveness and pharmacokinetic/pharmacodynamic (PKPD) properties remained unknown in higher species. We developed antibody–oligonucleotide conjugates (AOCs) towards mice or monkeys utilizing anti-TfR1 monoclonal antibodies (αTfR1) conjugated to various classes of oligonucleotides (siRNA, ASOs and PMOs). αTfR1 AOCs delivered oligonucleotides to muscle tissue in both species. In mice, αTfR1 AOCs achieved a > 15-fold higher concentration to muscle tissue than unconjugated siRNA. A single dose of an αTfR1 conjugated to an siRNA against Ssb mRNA produced > 75% Ssb mRNA reduction in mice and monkeys, and mRNA silencing was greatest in skeletal and cardiac (striated) muscle with minimal to no activity in other major organs. In mice the EC50 for Ssb mRNA reduction in skeletal muscle was >75-fold less than in systemic tissues. Oligonucleotides conjugated to control antibodies or cholesterol produced no mRNA reduction or were 10-fold less potent, respectively. Tissue PKPD of AOCs demonstrated mRNA silencing activity primarily driven by receptor-mediated delivery in striated muscle for siRNA oligonucleotides. In mice, we show that AOC-mediated delivery is operable across various oligonucleotide modalities. AOC PKPD properties translated to higher species, providing promise for a new class of oligonucleotide therapeutics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OligonucleotidesOligonucleotides, AntisenseMiceAnimalsAntibodiesRNA, Small InterferingRNA, MessengerMuscle, Skeletal

Substanzen

OligonucleotidesOligonucleotides, AntisenseAntibodiesRNA, Small InterferingRNA, Messenger

Autor:innen und Institutionen

  • Avidity Biosciences, Inc., 10578 Science Center Drive Suite 125, San Diego, CA 92121, USA.
  • Seawolf Therapeutics, One Sansome Street Suite 3630, San Francisco, CA 94104, USA.
  • CYTOO, 7 Parv. Louis Néel CS 20050, 38040 Grenoble, France.
  • California Northstate University College of Medicine, 9700 W Taron Dr, Elk Grove, CA 95757, USA.
  • Replicate Biosciences, 10210 Campus Point Dr, Suite 150, San Diego, CA 92121, USA.

Förderung

  • Avidity Biosciences, Inc

Zitieren

APA

Malecova, B., Burke, R. S., Cochran, M., Hood, M. D., Johns, R., Kovach, P. R., Doppalapudi, V. R., Erdogan, G., Arias, J. D., Darimont, B., Miller, C. D., Huang, H., Geall, A., Younis, H. S., & Levin, A. A. (2023). Targeted tissue delivery of RNA therapeutics using antibody–oligonucleotide conjugates (AOCs). Nucleic Acids Research, 51(12), 5901-5910. https://doi.org/10.1093/nar/gkad415

Vancouver

Malecova B, Burke RS, Cochran M, Hood MD, Johns R, Kovach PR, et al. Targeted tissue delivery of RNA therapeutics using antibody–oligonucleotide conjugates (AOCs). Nucleic Acids Research. 2023;51(12):5901-5910. doi:10.1093/nar/gkad415

BibTeX
@article{Malecova2023,
  author = {Malecova, Barbora and Burke, Rob S and Cochran, Michael and Hood, Michael D and Johns, Rachel and Kovach, Philip R and Doppalapudi, Venkata R and Erdogan, Gulin and Arias, J Danny and Darimont, Beatrice and Miller, Christopher D and Huang, Hanhua and Geall, Andrew and Younis, Husam S and Levin, Arthur A},
  title = {Targeted tissue delivery of RNA therapeutics using antibody–oligonucleotide conjugates (AOCs)},
  journal = {Nucleic Acids Research},
  year = {2023},
  volume = {51},
  number = {12},
  pages = {5901--5910},
  doi = {10.1093/nar/gkad415}
}
Kostenlos starten →